About 5 Trademarks found that are owned by Invizyne Technologies Inc.

Organic compounds for use in biotechnological and manufacturing processes and product development; organic compounds for use in the biochemical and chemical industries; organic compounds, namely, alcohols, fatty acids, esters, alkanes, alkenes, organic acids, indoles, flavonoids, flavonoids, polyketides, carotenoids, non-ribosomal peptides, lactones, aldehydes, alkaloids, isoprenoids, insect hormones, and plant hormones, for use in biotechnological manufacturing processes; organic compounds for use in biochemical and chemical industries, namely, pharmaceutical, energy, biofuel, food, beverage, dietary, nutritional, nutraceutical, flavor, fragrance, insect control, and agrochemical industries; organic compounds for use in the manufacture of biofuels; organic compounds for use in the manufacture of dietary and nutritional supplements; organic compounds for use in the manufacture of food and beverage products; none of the foregoing containing CBD, cannabinoids or tryptamines

SIMPLE PATH

The mark consists of a hexagon on the left side of an arrow pointing from left to right, all over the word "INVIZYNE".

Pharmaceuticals, namely, alcohols, esters, alkaloids, polyketides, steroids, isoprenoids, and non-ribosomal peptides, for use the treatment of pain, neuropathic pain, cancer pain, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, post-traumatic stress disorder, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse, epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome, chromosome disorders, and metabolic disorders; anti-inflammatories; analgesics; nutraceuticals for use as a dietary supplement; dietary and nutritional supplements; none of the foregoing containing CBD, cannabinoids or tryptamines

Organic compounds for use in biotechnological and manufacturing processes and product development; organic compounds for use in the biochemical and chemical industries; organic compounds, namely, alcohols, fatty acids, esters, alkanes, alkenes, organic acids, indoles, flavonoids, flavonoids, polyketides, carotenoids, non-ribosomal peptides, lactones, aldehydes, alkaloids, isoprenoids, insect hormones, and plant hormones, for use in biotechnological manufacturing processes; organic compounds for use in biochemical and chemical industries, namely, pharmaceutical, energy, biofuel, food, beverage, dietary, nutritional, nutraceutical, flavor, fragrance, insect control, and agrochemical industries; organic compounds for use in the manufacture of biofuels; organic compounds for use in the manufacture of dietary and nutritional supplements; organic compounds for use in the manufacture of food and beverage products; none of the foregoing containing CBD, cannabinoids or tryptamines

Organic compounds for use in biotechnological manufacturing processes and product development; organic compounds for use in the biochemical and chemical industries; organic compounds for use in connection with energy generation; organic compounds for use in the manufacture of dietary and nutritional supplements; organic compounds for use in food and beverage products